HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiong Shi Selected Research

2- methyl- 1- ((4- methyl- 5- isoquinolinyl)sulfonyl)homopiperazine

1/2021A high-content screen identifies the vulnerability of MYC-overexpressing cells to dimethylfasudil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiong Shi Research Topics

Disease

62Neoplasms (Cancer)
03/2022 - 09/2004
26Glioma (Gliomas)
11/2017 - 05/2012
22Melanoma (Melanoma, Malignant)
01/2022 - 01/2016
8Inflammation (Inflammations)
01/2022 - 03/2009
8Vitiligo
01/2020 - 02/2013
8Neoplasm Metastasis (Metastasis)
01/2020 - 01/2006
8Carcinogenesis
09/2017 - 01/2010
8Osteosarcoma (Osteogenic Sarcoma)
10/2015 - 01/2010
8Colorectal Neoplasms (Colorectal Cancer)
01/2013 - 09/2004
4Hepatocellular Carcinoma (Hepatoma)
05/2019 - 03/2013
3Polyploidy
03/2022 - 01/2020
3Non-alcoholic Fatty Liver Disease
07/2021 - 12/2019
3Body Weight (Weight, Body)
12/2019 - 10/2009
3Breast Neoplasms (Breast Cancer)
05/2016 - 08/2013
3Spontaneous Abortion (Miscarriage)
01/2012 - 05/2008
3Colonic Neoplasms (Colon Cancer)
08/2011 - 11/2008
3Adenoma (Adenomas)
11/2008 - 09/2004
2Aortic Valve Disease
06/2022 - 01/2022
2Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 08/2019
2Infections
12/2021 - 05/2016
2Triple Negative Breast Neoplasms
07/2021 - 04/2020
2Pulmonary Hypertension
01/2020 - 01/2019
2Squamous Cell Carcinoma of Head and Neck
01/2018 - 01/2017
2Glioblastoma (Glioblastoma Multiforme)
11/2015 - 05/2013
2Ataxia Telangiectasia (Louis Bar Syndrome)
07/2015 - 11/2011
2Psoriasis (Pustulosis Palmaris et Plantaris)
11/2014 - 09/2013
2Carcinoma (Carcinomatosis)
08/2013 - 09/2004
2Osteoporotic Fractures
11/2010 - 07/2010

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
12/2021 - 07/2007
9MicroRNAs (MicroRNA)IBA
01/2022 - 01/2012
8Phosphotransferases (Kinase)IBA
10/2019 - 10/2012
8CateninsIBA
01/2015 - 01/2011
7Messenger RNA (mRNA)IBA
01/2020 - 05/2008
6Biological ProductsIBA
01/2020 - 05/2012
5EnzymesIBA
01/2022 - 07/2017
5Pharmaceutical PreparationsIBA
11/2021 - 08/2013
5CytokinesIBA
07/2021 - 09/2015
5Biomarkers (Surrogate Marker)IBA
09/2017 - 04/2014
5ProstaglandinsIBA
08/2011 - 09/2004
4Glucose (Dextrose)FDA LinkGeneric
07/2021 - 10/2009
4Interleukin-8 (Interleukin 8)IBA
07/2021 - 05/2016
4LigandsIBA
12/2020 - 01/2006
4PhosphoproteinsIBA
11/2017 - 04/2013
4ErbB Receptors (EGF Receptor)IBA
11/2017 - 01/2006
4Protein Kinases (Protein Kinase)IBA
10/2015 - 11/2009
4Small Interfering RNA (siRNA)IBA
01/2015 - 08/2013
4Prostaglandins EIBA
08/2011 - 09/2004
3CalciumIBA
06/2022 - 01/2020
3RNA (Ribonucleic Acid)IBA
01/2022 - 08/2009
3Alkaline PhosphataseIBA
01/2022 - 01/2020
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2018
3Therapeutic UsesIBA
01/2022 - 03/2020
3Tyrosine (L-Tyrosine)FDA Link
01/2021 - 10/2012
3quinone (benzoquinone)IBA
05/2019 - 11/2015
3Growth Differentiation Factor 2IBA
02/2014 - 11/2010
3Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2010 - 01/2010
2Aurora Kinase BIBA
03/2022 - 01/2020
2Triglycerides (Triacylglycerol)IBA
07/2021 - 12/2019
2Serine (L-Serine)FDA Link
01/2021 - 01/2015
2Long Noncoding RNAIBA
01/2021 - 01/2020
2VemurafenibIBA
12/2020 - 01/2020
2Oleic Acid (Oleate)IBA
01/2020 - 12/2019
2potassium channel subfamily K member 3IBA
01/2020 - 01/2019
2SuspensionsIBA
01/2020 - 05/2012
2Mechanistic Target of Rapamycin Complex 1IBA
12/2019 - 11/2017
2Peptides (Polypeptides)IBA
08/2019 - 11/2009
2Polychlorinated Biphenyls (PCBs)IBA
05/2019 - 11/2015
2HMGB1 Protein (HMG1)IBA
05/2019 - 10/2016
2Cytochromes c (Cytochrome c)IBA
01/2019 - 07/2015
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 01/2016
2Metalloproteases (Metalloproteinases)IBA
01/2018 - 10/2012
2Ubiquitin-Specific ProteasesIBA
01/2018 - 04/2014
2Conotoxins (Conotoxin)IBA
12/2017 - 01/2017
2Peptide Initiation Factors (Initiation Factor)IBA
11/2017 - 07/2017
2LipidsIBA
10/2017 - 12/2010
2TransducinIBA
09/2017 - 06/2015
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
09/2017 - 06/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
07/2017 - 05/2013
2Monomeric GTP-Binding ProteinsIBA
01/2017 - 04/2013
2MelatoninIBA
01/2017 - 03/2009
2tetrachlorobenzoquinoneIBA
12/2016 - 07/2015
2Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
07/2016 - 08/2013
2Complementary DNA (cDNA)IBA
05/2016 - 02/2015
22,3,5- trichloro- 6- phenyl- (1,4)benzoquinoneIBA
11/2015 - 07/2015
2BromidesIBA
10/2015 - 03/2013
2plumbaginIBA
07/2015 - 02/2015
2Cadherins (E-Cadherin)IBA
01/2015 - 05/2013
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2014 - 08/2013
2Transforming Growth Factors (Transforming Growth Factor)IBA
02/2014 - 08/2013
2Doxorubicin (Adriamycin)FDA LinkGeneric
08/2013 - 02/2011
2geranylgeranyltransferase type-I (protein geranylgeranyltransferase)IBA
05/2013 - 01/2013
2S100 Proteins (S 100 Protein)IBA
03/2013 - 01/2013
2PPAR gammaIBA
04/2010 - 01/2010
2Oxygen (Dioxygen)IBA
11/2009 - 08/2009
2Dinoprostone (PGE2)FDA Link
04/2006 - 02/2006
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2006 - 09/2004

Therapy/Procedure

23Therapeutics
01/2022 - 11/2009
7Drug Therapy (Chemotherapy)
09/2019 - 02/2011
5Immunotherapy
01/2022 - 10/2018
2Excimer Lasers
05/2013 - 02/2013